Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Additive protection by antioxidant and apoptosis-inhibiting effects on mosquito cells with dengue 2 virus infection.

Chen TH, Lo YP, Yang CF, Chen WJ.

PLoS Negl Trop Dis. 2012;6(4):e1613. doi: 10.1371/journal.pntd.0001613. Epub 2012 Apr 17.

2.

Antioxidant defense is one of the mechanisms by which mosquito cells survive dengue 2 viral infection.

Chen TH, Tang P, Yang CF, Kao LH, Lo YP, Chuang CK, Shih YT, Chen WJ.

Virology. 2011 Feb 20;410(2):410-7. doi: 10.1016/j.virol.2010.12.013. Epub 2011 Jan 8.

3.

Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.

Laosutthipong C, Kanthong N, Flegel TW.

Antiviral Res. 2013 Jun;98(3):449-56. doi: 10.1016/j.antiviral.2013.04.011. Epub 2013 Apr 17.

PMID:
23603496
4.

Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan.

Talarico LB, Noseda MD, Ducatti DR, Duarte ME, Damonte EB.

J Gen Virol. 2011 Jun;92(Pt 6):1332-42. doi: 10.1099/vir.0.028522-0. Epub 2011 Feb 16.

PMID:
21325483
5.

Narasin, a novel antiviral compound that blocks dengue virus protein expression.

Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.

Antivir Ther. 2011;16(8):1203-18. doi: 10.3851/IMP1884.

PMID:
22155902
6.

Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.

Alen MM, Dallmeier K, Balzarini J, Neyts J, Schols D.

Antiviral Res. 2012 Dec;96(3):280-7. doi: 10.1016/j.antiviral.2012.10.007. Epub 2012 Oct 31.

PMID:
23124109
7.

Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.

Acosta EG, Piccini LE, Talarico LB, Castilla V, Damonte EB.

Virus Res. 2014 May 12;184:39-43. doi: 10.1016/j.virusres.2014.02.011. Epub 2014 Feb 25.

PMID:
24583230
8.

Development and characterization of a stable luciferase dengue virus for high-throughput screening.

Zou G, Xu HY, Qing M, Wang QY, Shi PY.

Antiviral Res. 2011 Jul;91(1):11-9. doi: 10.1016/j.antiviral.2011.05.001. Epub 2011 May 7.

PMID:
21575658
9.

The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.

Talarico LB, Pujol CA, Zibetti RG, Faría PC, Noseda MD, Duarte ME, Damonte EB.

Antiviral Res. 2005 Jun;66(2-3):103-10. Epub 2005 Feb 26.

PMID:
15911027
10.

Asymmetric competitive suppression between strains of dengue virus.

Pepin KM, Lambeth K, Hanley KA.

BMC Microbiol. 2008 Feb 8;8:28. doi: 10.1186/1471-2180-8-28.

11.
12.

Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection.

Neves-Souza PC, Azeredo EL, Zagne SM, Valls-de-Souza R, Reis SR, Cerqueira DI, Nogueira RM, Kubelka CF.

BMC Infect Dis. 2005 Aug 18;5:64.

13.

Dengue virus infection of SK Hep1 cells: inhibition of in vitro angiogenesis and altered cytomorphology by expressed viral envelope glycoprotein.

Basu A, Jain P, Sarkar P, Gangodkar S, Deshpande D, Ganti K, Shetty S, Ghosh K.

FEMS Immunol Med Microbiol. 2011 Jul;62(2):140-7. doi: 10.1111/j.1574-695X.2011.00794.x. Epub 2011 Mar 16.

14.

Dengue virus utilizes calcium modulating cyclophilin-binding ligand to subvert apoptosis.

Li J, Huang R, Liao W, Chen Z, Zhang S, Huang R.

Biochem Biophys Res Commun. 2012 Feb 24;418(4):622-7. doi: 10.1016/j.bbrc.2012.01.050. Epub 2012 Jan 18.

PMID:
22281498
15.

Antiviral action of nitric oxide on dengue virus type 2 replication.

Takhampunya R, Padmanabhan R, Ubol S.

J Gen Virol. 2006 Oct;87(Pt 10):3003-11.

PMID:
16963759
16.

Dengue virus isolation relying on antibody-dependent enhancement mechanism using FcγR-expressing BHK cells and a monoclonal antibody with infection-enhancing capacity.

Moi ML, Lim CK, Tajima S, Kotaki A, Saijo M, Takasaki T, Kurane I.

J Clin Virol. 2011 Nov;52(3):225-30. doi: 10.1016/j.jcv.2011.07.009. Epub 2011 Aug 6.

PMID:
21824813
17.

Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells.

Li YG, Siripanyaphinyo U, Tumkosit U, Noranate N, A-nuegoonpipat A, Tao R, Kurosu T, Ikuta K, Takeda N, Anantapreecha S.

Intervirology. 2013;56(1):6-12. doi: 10.1159/000339985. Epub 2012 Aug 16.

PMID:
22907160
18.

Inhibition of dengue virus by an ester prodrug of an adenosine analog.

Chen YL, Yin Z, Lakshminarayana SB, Qing M, Schul W, Duraiswamy J, Kondreddi RR, Goh A, Xu HY, Yip A, Liu B, Weaver M, Dartois V, Keller TH, Shi PY.

Antimicrob Agents Chemother. 2010 Aug;54(8):3255-61. doi: 10.1128/AAC.00397-10. Epub 2010 Jun 1.

19.

Endothelial cell surface expression of protein disulfide isomerase activates β1 and β3 integrins and facilitates dengue virus infection.

Wan SW, Lin CF, Lu YT, Lei HY, Anderson R, Lin YS.

J Cell Biochem. 2012 May;113(5):1681-91. doi: 10.1002/jcb.24037.

PMID:
22422622
20.

Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock related protein.

Salas-Benito J, Reyes-Del Valle J, Salas-Benito M, Ceballos-Olvera I, Mosso C, del Angel RM.

Am J Trop Med Hyg. 2007 Aug;77(2):283-90.

PMID:
17690400

Supplemental Content

Support Center